New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
09:08 EDTMPEL, SAAS, MCP, OGXI, ATML, THOR, RIG, SUNE, CTIC, HZNP, WAG, XONE, SSYS, DDD, FOXAOn The Fly: Pre-market Movers
HIGHER: 21st Century Fox (FOXA), up 5.8%, upgraded at Cowen following the company's Q4 earnings results... Walgreen (WAG), up 2.8% after upgraded at Cantor... inContact (SAAS), up 18.5% after upgraded at Oppenheimer and Benchmark Co. after reporting better than expected Q2 results... CTI BioPharma (CTIC), up 4.5% after Pacritinib granted fast track designation by FDA... Stratasys (SSYS), up 8.6% after reporting earnings and raising its FY14 EPS view. Peers higher as well, with ExOne (XONE) up 5.3% and 3D Systems (DDD) up 2.9%... OncoGenex (OGXI), up 11.3% after appointing John A. Bencich CFO. UP AFTER EARNINGS: Horizon Pharma (HZNP), up 14.6%... Goodrich Petroleum (GDP), up 11.1%... SunEdison (SUNE), up 7%... Transocean (RIG), up 2.8%... Molycorp (MCP), up 13.7%. LOWER: Nanosphere (NSPH), down 31%, downgraded at Craig-Hallum following the company's Q2 earnings results... Thoratec (THOR), down 26%, downgraded at Goldman and Credit Suisse following lower than expected second quarter revenues and lowering FY14 guidance... PhotoMedex (PHMD), down 10% after earnings, disclosing receipt of notice of default on credit facilities... Atmel (ATML), down 4.2%, downgraded at BofA Merrill Lynch following its Q2 earnings results... Melco Crown (MPEL), down 5.2% after earnings, reporting Taiwan branch office indicted for alleged banking violations.
News For FOXA;SSYS;DDD;XONE;WAG;HZNP;CTIC;SUNE;RIG;THOR;ATML;OGXI;SAAS;MCP;MPEL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
March 17, 2015
16:00 EDTRIGOptions Update; March 17, 2015
iPath S&P 500 VIX Short-Term Futures down 11c to 27.30. Option volume leaders: AAPL RIG MGM HTZ TWTR TSLA CY KO NFLX C according to Track Data.
13:06 EDTFOXABattleground: Analysts take opposite sides on Netflix
Subscribe for More Information
12:38 EDTCTICCTI BioPharma management to meet with Piper Jaffray
Subscribe for More Information
11:36 EDTFOXAApple may launch standalone TV in 2016, says Piper Jaffray
Subscribe for More Information
10:00 EDTXONEOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:25 EDTXONE, MCPOn The Fly: Pre-market Movers
Subscribe for More Information
07:49 EDTMCPJPMorgan 'very concerned' about Molycorp capital levels
Subscribe for More Information
07:40 EDTXONEExOne guidance 'pretty good,' says Oppenheimer
Subscribe for More Information
05:39 EDTXONEExOne downgraded to Market Perform from Outperform at FBR Capital
Subscribe for More Information
March 16, 2015
19:00 EDTMCP, XONEOn The Fly: After Hours Movers
Subscribe for More Information
17:31 EDTMCPMolycorp reports Q4 EPS (39c), consensus (26c)
Subscribe for More Information
17:18 EDTXONEExOne sees FY15 revenue $58M-$66M, consensus $61.77M
Subscribe for More Information
17:17 EDTXONEExOne reports Q4 EPS (50c), may not compare to consensus (5c)
Subscribe for More Information
15:25 EDTMCPNotable companies reporting after market close
Subscribe for More Information
10:02 EDTMPELOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:15 EDTCTICCTI BioPharma shares should be bought on weakness, says Roth Capital
Subscribe for More Information
08:04 EDTMPELMelco Crown downgraded to Equal Weight from Overweight at Morgan Stanley
Subscribe for More Information
07:53 EDTXONEExOne March volatility elevated at 135 into Q4 and outlook
Subscribe for More Information
07:44 EDTMCPmagicJack volatility elevated into Q4 and outlook
magicJack March call option implied volatility is at 83, April is a 124, April is at 71, June is at 61, September is at 50; compared to its 26-week average of 58 according to Track Data, suggesting large near term price movement into the expected release of Q4 results today after the market close.
05:27 EDTCTICCTI BioPharma announces publication of Phase 2 pacritinib study results
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use